BioSpace News Archive

The Bristol-Myers Squibb-Pfizer Alliance today announced the initiation of a new randomized, controlled study, GUARD-AF (ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals)

Konica Minolta Healthcare Americas, Inc., announces recent installations of the SONIMAGE® HS1 Compact Ultrasound System and the SONIMAGE® MX1 Portable Ultrasound System at several prestigious healthcare institutions and sports medicine practices throughout the US.

ALS Association Golden West Chapter Honors MTPA as a Champion in the Search for ALS Treatments

HealthLynked Corp. (OTCQB: HLYK), a provider of healthcare-related technology that connects doctors, patients and medical data, today reported its financial results for the three months ended September 30, 2019.

Epiphany Dermatology announced it has expanded its national presence into Montana through its partnership with Advanced Dermatology of Butte.

RemeGen, Ltd. today announced a Phase IIb clinical trial of RC18 (telitacicept), a potential new medicine for the treatment of systemic lupus erythematosus (SLE), met its primary endpoint of a greater than 4-point reduction in the SLE Responder Index (SRI4).

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) (“QIAGEN” or the “Company”) announces it has begun a review of potential strategic alternatives after receiving several conditional, non-binding indications of interest for the acquisition of all issued and outstanding shares of the Company.

Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced that the Aimmune executive management team will participate in three upcoming investor conferences in November and December:

Amyris, Inc. (Nasdaq: AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it has closed on its previously announced contemplated transactions providing for the purchase of its existing CVI Heights convertible note by two “accredited investors

So-Young International Inc. announced that it will report its financial results for the third quarter ended September 30, 2019, before U.S. markets open on December 5, 2019.